Brief: Illumina Enhances Flagship Assay To Accelerate Access To Comprehensive Tumor Profiling
30/07/2025 14:58
July 30 (Reuters) - Illumina Inc ILMN.O: ILLUMINA ENHANCES FLAGSHIP ASSAY TO ACCELERATE ACCESS TO COMPREHENSIVE TUMOR PROFILING Source text: ID:nPn29ngJma Further company coverage: ILMN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Illumina
See all newsBrief: Illumina Bioinsight Platform Expands With New Software To Accelerate The Path From Sequencing To Discovery
US RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Brief: Illumina - Establishes Unsecured Commercial Paper Program On October 8, 2026
Brief: Illumina To Announce Third Quarter 2026 Financial Results
Brief: Illumina Releases Spliceai2 To Help Advance Rare Disease Research